What is spinocellular tongue cancer?

Squamalus cell carcinoma is one of the most common types of language cancer. Symptoms vary depending on the location of the tumor and the stage of the disease. Medical experts treat this cancer by radiation, chemotherapy and surgery. Patients can also experience bleeding from the tongue or insensitivity of the mouth. Individuals can rarely experience ear pain or voice changes. Patients who have advanced cancer can develop problems with jathers or anemia.

Squamalus cell carcinoma usually affects people over 50 years of age and men develop this disease three times the level of women. About 80% of all people who develop tongue cancer are smokers. Other risk factors include chewing tobacco or smokeless tobacco, severe use of alcohol and chronic oral survey from dental cavities or other problems in the mouth.

medical experts diagnose the disease by making a biopsy of an area thatá is affected. They can also perform X -rays of the chest to look for cancer in the lungs or order a computer tomography (CT) to scan the neck and head to look for cancer in the lymph nodes. In the procedure called endoscopy, the medical professional inserts a small camera on a long, narrow tube into the body to project tumors or cancer cells in the larynx, bronchial tubes or esophagus.

small tumors on the tongue can be surgically removed. Patients whose cancer has spread to the lymph nodes may require further surgery called neck dissections. This procedure often leads to a loss of one or both lymph nodes, but reduces the possibility of returning cancer. Patients may also be treated with radiation or chemotherapy.

Surgery for spinocellular tongue cancer often disappears. Some patients decide to have reconstructive surgery after removal of the tumor. Patients with tongue cancer sometimes have problems with speaking, food or swallowit after their operation.

survival prognosis varies depending on the patient. Those whose cancer is diagnosed soon have a chance to remain without cancer for five years after treatment. The probability decreases to about 30% in individuals who are diagnosed in later stages of the disease. Patients whose cancer spread to lymph nodes or lungs at the time of diagnosis have less than 50% chance of survival.